ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,306,233 | +127.7% | 501,355 | +401.4% | 0.02% | +60.0% |
| Q4 2022 | $1,013,000 | -87.3% | 100,000 | -86.6% | 0.01% | -89.0% |
| Q2 2022 | $7,952,000 | -52.9% | 746,652 | -56.9% | 0.09% | -51.1% |
| Q1 2022 | $16,885,000 | -16.7% | 1,731,812 | +22.2% | 0.19% | -20.2% |
| Q4 2021 | $20,268,000 | +1308.5% | 1,417,363 | +1873.5% | 0.23% | +1194.4% |
| Q3 2021 | $1,439,000 | -70.9% | 71,820 | -68.1% | 0.02% | -68.4% |
| Q2 2021 | $4,950,000 | -27.1% | 225,000 | +12.5% | 0.06% | -35.2% |
| Q1 2021 | $6,792,000 | -32.5% | 200,000 | -20.0% | 0.09% | -38.0% |
| Q4 2020 | $10,060,000 | – | 250,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |